The results of the study conducted by Lau et al. [41] revealed that the IL18 (−137G >C) polymorphism is strongly correlated with an elevated risk of hepatocellular carcinoma, but the (607C >A) rs1946518 polymorphism did not show a significant association with hepatocellular carcinoma susceptibility. Here, IL18 is linked to hepatocellular carcinoma.